about
Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patientsProbiotics for vulvovaginal candidiasis in non-pregnant womenProbiotics for fibromyalgiaProbiotics for preventing preterm labourProbiotics for preventing preterm labourProbiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparationsRole and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An updateAntimicrobial activity of a multispecies probiotic (Ecologic 641) against pathogens isolated from infected pancreatic necrosisThe Lactobacillus plantarum strain ACA-DC287 isolated from a Greek cheese demonstrates antagonistic activity in vitro and in vivo against Salmonella enterica serovar TyphimuriumUse of colony-based bacterial strain typing for tracking the fate of Lactobacillus strains during human consumption.Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model.Application of sequence-dependent electrophoresis fingerprinting in exploring biodiversity and population dynamics of human intestinal microbiota: what can be revealed?L. plantarum prevents enteroinvasive Escherichia coli-induced tight junction proteins changes in intestinal epithelial cellsA novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells.Proteins of novel lactic acid bacteria from Apis mellifera mellifera: an insight into the production of known extra-cellular proteins during microbial stress.A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients.Lactobacillus plantarum prevents the development of colitis in IL-10-deficient mouse by reducing the intestinal permeability.Sustained delivery of commensal bacteria from pod-intravaginal rings.Prebiotic and probiotic fortified milk in prevention of morbidities among children: community-based, randomized, double-blind, controlled trialImpact of emergency department probiotic treatment of pediatric gastroenteritis: study protocol for the PROGUT (Probiotic Regimen for Outpatient Gastroenteritis Utility of Treatment) randomized controlled trial.Multiple effects of Escherichia coli Nissle 1917 on growth, biofilm formation, and inflammation cytokines profile of Clostridium perfringens type A strain CP4.The antimicrobial effects of selenium nanoparticle-enriched probiotics and their fermented broth against Candida albicansSurvival of probiotic lactobacilli in acidic environments is enhanced in the presence of metabolizable sugarsEffect of Bifidobacterium animalis on mice infected with Strongyloides venezuelensisProbiotics for disease prevention: a focus on ventilator-associated pneumonia.pH-, Lactic acid-, and non-lactic acid-dependent activities of probiotic Lactobacilli against Salmonella enterica Serovar Typhimurium.Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic ScienceProtective effects of Lactobacillus plantarum against epithelial barrier dysfunction of human colon cell line NCM460.Bile salt hydrolase activity in probiotics.A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters.The rationale and potential for the reduction of oral malodour using Streptococcus salivarius probiotics.Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements.Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier functionScience and regulation. Probiotics: finding the right regulatory balance.Essential roles of monocytes in stimulating human peripheral blood mononuclear cells with Lactobacillus casei to produce cytokines and augment natural killer cell activityAdvantageous direct quantification of viable closely related probiotics in petit-suisse cheeses under in vitro gastrointestinal conditions by Propidium Monoazide--qPCR.Probiotics as efficient immunopotentiators: translational role in cancer prevention[Intestinal microbiota and cardiometabolic risk: mechanisms and diet modulation].The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition.Inhibition of Staphylococcus aureus by lysostaphin-expressing Lactobacillus plantarum WCFS1 in a modified genital tract secretion medium
P2860
Q21195017-329130A5-09B8-479D-9007-3BD7586C638FQ24198021-71EFE9A8-0060-4B98-8431-E4A524B3610AQ24200363-C79FEE26-6FCF-4441-9136-0DA58F1CE24DQ24244075-88A851ED-95AF-43E0-96AE-BCF798B2DAC1Q24246388-067BC438-6BE4-4E1C-BF98-05C268781F9AQ24679315-87B63A41-DCF7-45E0-B8F1-BFF1B36E3738Q26746916-95677F0E-4860-4271-B837-29057DEB1E6BQ28253794-27B39105-47C3-48D2-BF0B-076E76C694BAQ29397388-BB1F15F0-A5F7-4023-91B2-06DF2BFEA58DQ30962447-FA90F200-A611-41C5-9718-77428D4361DFQ33410248-C49D8B71-10E0-48D0-B24F-EFDC0889EDD7Q33416742-7C1B6494-2AAA-4308-9FC7-FFD628C90F22Q33424095-E9B8C2D7-C023-44F5-B0DE-827641636850Q33528981-EBD46ECC-3956-4BD3-A889-82903A8E6571Q33589695-6BC0CA32-ABF0-4C64-8F96-41EB5D9BD9B7Q33590786-F289A63B-0C9F-4B46-A2CD-4B0A4CBBDB2DQ33613698-AC70C337-A600-490E-8EA8-DE1A3F8C5202Q33622882-9748B50C-C777-4B9C-A2D5-58F079E0F1D5Q33668674-FDF9AE52-4A64-4682-A32A-8187747B1727Q33682584-035A95BB-7FF9-439B-BD58-495AD12DFE16Q33684740-22FB24ED-BF95-42D0-BB2B-9C5CEE75EABDQ33768278-2A4B8269-9436-48DB-8405-AE3E5996AA67Q33855902-98FC2AD2-FC40-453B-A00C-15D4B9B93999Q33859682-6BC049C1-2F7B-4FE8-859C-B8D7C34DACD0Q34033644-A96B5232-355B-457C-94A9-013852E83DB3Q34098013-9975D398-127A-4B5E-AAEA-ECFF9AB181DEQ34162963-1603F220-0600-4358-BB3D-7172C7D5D599Q34385197-8ED614EE-5F74-45F8-9090-9B3781C300F4Q34432358-1F998497-5782-4FD0-B24B-0DDF525EC51AQ34504185-D431EDCD-9819-4403-841A-DF4A3E3B3F7DQ34555773-4D5A659C-2369-4F97-B091-42B1F2FF4483Q34559453-2FB5230F-B5EA-4F21-B0BA-E0DE508A75F3Q34587671-535B4510-D8CD-4343-AC1C-8206DE297436Q35020179-B8ADF01D-44CD-41CD-A83D-B13C15033196Q35023410-8A5479DF-FD05-4ADC-BE62-FAB9A65A2FD0Q35072607-8AFA2B33-A393-4FD0-86BC-A8BCA5C1A5FCQ35085664-7AA9D25C-F63A-4682-B20E-A3778DF330ACQ35189484-C2467574-0A2E-4ADC-8591-F3457080B7B7Q35571641-0C4E72AF-2C52-48FD-B3E7-1E9C80BCB0A2Q35599270-D7E9CCAD-AB58-4E2B-8A26-EAEF1BF69E99
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Potential uses of probiotics in clinical practice
@ast
Potential uses of probiotics in clinical practice
@en
Potential uses of probiotics in clinical practice
@nl
type
label
Potential uses of probiotics in clinical practice
@ast
Potential uses of probiotics in clinical practice
@en
Potential uses of probiotics in clinical practice
@nl
prefLabel
Potential uses of probiotics in clinical practice
@ast
Potential uses of probiotics in clinical practice
@en
Potential uses of probiotics in clinical practice
@nl
P2093
P2860
P3181
P1476
Potential uses of probiotics in clinical practice
@en
P2093
Gregor Reid
M Tom Sebulsky
P2860
P304
P3181
P356
10.1128/CMR.16.4.658-672.2003
P407
P577
2003-10-01T00:00:00Z